JPRN-UMIN000052443招募中Unknown
A prospective, open-label, single-centre, randomized study to evaluate coronary microcirculation in de-novo lesions treated with drug-coated balloons or drug-eluting stents - NEO D5 study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- Other
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) left ventricular ejection fraction <30% (2) known renal failure (creatinine >2mg/dl) (3) acute myocardial infarction within the previous 48 hours (4) history of severe valvular heart disease or hypertrophic cardiomyopathy (5) previous intervention to the same vessel (6) life expectancy <1 year (7) inappropriate lesion for assessment of microcirculation (i.e., left main lesions, ostial lesions, heavily calcified lesions, thrombotic lesions)
研究者
相似试验
进行中（未招募）
不适用
A single-center, prospective, open-label, randomized, comparative, and placebocontrolled observation study for effect of using Mobile App-based Human Coaching Program on NAFLDDiseases of the digestive systemKCT0007695Yonsei University Health System, Severance Hospital100
尚未招募
Unknown
A single-center randomized, open-label, prospective study to evaluate efficacy and safety of DDK(Drug delivery kit, Welpass) for pain relief after gynecologic laparotomy surgeryKCT0008852Asan Medical Center110
尚未招募
4 期
Investigating the effect and safety of NEERI® Tablet and Syrup on kidney stonesCTRI/2023/07/054784Aimil Pharmaceuticals (India) Ltd.
进行中（未招募）
不适用
Clinical study comparing the effect of tropicamid eyedrops with cyclopentolat eyedrops for the assessment of bad eyesight in 4-6-year old childreCycloplegia for objective refraction measurementMedDRA version: 18.1Level: PTClassification code 10001906Term: AmblyopiaSystem Organ Class: 10015919 - Eye disordersEUCTR2015-000268-32-DEniversitätsklinikum Erlangen
进行中（未招募）
1 期
Study to evaluate 3 type of treatment (masitinib + FOLFIRI, or masitinib alone, or FOLFIRI alone) in the treatment of patients with metastatic colorectal cancer that have received 2 or 3 previous therapiesMetastatic colorectal cancer after 2 or 3 previous lines of treatmentMedDRA version: 17.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2013-000493-30-ESAB Science75